SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Catalent looks to go public with $100m IPO

30-Jan-2014 - Catalent has filed an initial public offering (IPO) with the SEC to raise $100m though this could reach upwards of $500m, according to one investment firm.

News in brief

GVK Bio to move into US with Aragen Purchase

30-Jan-2014 - Asia’s leading small-molecule CRO GVK BIO will acquire the capital stock of US-based CRO Aragen Bioscience. 

CRL looks to strategic alliances to drive growth across changing clientbase

20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).

McKesson's strategy unclear after $8.3bn Celsio takeover falls through

14-Jan-2014 - Whether McKesson will relaunch its bid to acquire German logistics firm Celsio has been questioned by analysts after the proposed $8.3bn (€6.1bn) takeover bid fell through.

Merck Millipore sells its discovery and development service biz to Eurofins

09-Jan-2014 - Merck Millipore has sold its Discovery and Development Solutions (DDS) Business to Eurofins saying it was unable to fully support.

Patheon third largest CMO and top PDS provider, report says as DSM merger looms

08-Jan-2014 - Patheon is the world’s largest pharmaceutical development services (PDS) provider and third largest contract manufacturer, according to a report released yesterday.

Cyprotex buys CeeTox to expand preclinical services biz

02-Jan-2014 - Cyprotex has bought CeeTox in a bid to diversify its revenue base beyond its core pharmaceutical preclinical services business.

Chiltern consolidates ownership after Kester Capital sells stake

19-Dec-2013 - A private equity investor has sold its stake in CRO Chiltern leading to a restructured ownership the firm says will encourage expansion.

Algorithme teams with Montreal hospital to expand breadth of services

12-Dec-2013 - Algorithme Pharma has increased early stage patient access by teaming with a Montreal hospital, and says it provides a breadth of therapeutic areas not normally associated with mid-sized CROs.

Venn continues growth with $1.1m purchase of Northern Irish CRO

10-Dec-2013 - Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.

Patheon announces UK expansion and posts improved financials for fiscal 2013

03-Dec-2013 - Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.

Dispatches from PCT

Parexel: Strategic partnerships are reshaping the CRO industry

02-Dec-2013 - Strategic partnerships are “the next phase” of sponsor-CRO relations, according to Parexel, and on top of saving pharma on oversight costs will reshape the industry. 

Dispatches from PCT

Not all good news: CROs must prepare for Private Equity exit, experts say

02-Dec-2013 - Private equity will be looking to exit the CRO industry and could pose a threat to recent strong growth, according to financial experts at PCT

Dispatches from PCT

Quintiles is the "arms, legs and brain" in Merck Serono's monogamous relationship

02-Dec-2013 - Trust, transparency and end-to-end participation are just some of the reasons Merck Serono says its exclusive strategic partnership with Quintiles is the “first of its kind.”

Venn acquires German CRO and says there's more to come

18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.

breaking news

PRA to buy CRI Lifetree

13-Nov-2013 - US CRO PRA International has announced plans to buy privately-owned early phase trial specialist CRI Lifetree.

UPDATE

'CROs on the move': inVentiv's new UK site; Novum in North Dakota

29-Oct-2013 - inVentiv Health has opened a new UK office in order to better target European customers, whilst Novum says its North Dakota facility will strengthen its offerings.

Aenova growing through consolidation with Haupt acquisition

28-Oct-2013 - CDMO Aenova has continued its strategy of consolidation with the acquisition of Haupt Pharma.

McKesson pushes for global reach with $8.3bn Celesio deal

28-Oct-2013 - McKesson Group has completed the acquisition of logistics firm Celesio as it eyes a global strategy, targeting the European and Latin America markets.

DrugDev acquires site payment specialist CFS Clinical

22-Oct-2013 - Sponsor network developer DrugDev on Monday announced it would acquire CFS Clinical, which specializes in managing the financing of clinical trials.  Financial terms were not disclosed.

DPT fielding calls from Ben Venue customers

17-Oct-2013 - US contractor DPT says it has received calls from customers of soon-to-close CMO Ben Venue Labs.

Catalent's Brazilian acquisition supports global softgel strategy

10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.

McKesson rumoured to be eyeing up Celesio; New CFO - People Gallery

10-Oct-2013 - McKesson Corporation who is said to be in talks to acquire German logistics company Celesio has appointed a new CFO and Executive Director - Welcome to Outsourcing-Pharma's People on the Move....

Cambridge Major Labs and AAIPharma Merge

08-Oct-2013 - AAIPharma says the merger with Cambridge Major Laboratories (CML) will bring clients the benefits of integrated Chemistry and Manufacturing Controls (CMC) services from two high-growth CMOs.

WCCT eyes niche market with early-stage opthalmic acquisition

26-Sep-2013 - WCCT Global has acquired OC Clinical Trials & Consulting to boost its early-stage ophthalmology services and fill a gap in the market, the firm says.

Key Industry Events

 

Access all events listing

Our events, Events from partners...